Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.14 | -$0.11 | -$0.13 |
| Q2 2025 | 3 | -$0.13 | -$0.11 | -$0.12 |
| Q3 2025 | 3 | -$0.12 | -$0.12 | -$0.12 |
| Q4 2025 | 2 | -$0.10 | -$0.10 | -$0.10 |
| Q1 2026 | 2 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2026 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q4 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q1 2027 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q2 2027 | 1 | $0.02 | $0.02 | $0.02 |
AngioDynamics, Inc. last posted its earnings results on Thursday, October 2nd, 2025. The company reported $-0.1 earnings per share for the quarter, topping analysts' consensus estimates of $-0.14 by $0.04. The company had revenue of 75.71 M for the quarter and had revenue of 292.50 M for the year. AngioDynamics, Inc. has generated $-1 earnings per share over the last year ($-0.83 diluted earnings per share) and currently has a price-to-earnings ratio of -17.28. AngioDynamics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, January 8th, 2026 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/02/2025 | Q1 2026 | -$0.14 | -$0.26 | -0.12 | $72.29 M | $75.71 M |
| 07/18/2025 | Q4 2025 | N/A | -$0.15 | N/A | $74.26 M | $80.16 M |
| 04/02/2025 | Q3 2025 | -$0.13 | -$0.11 | 0.02 | $70.30 M | $72.00 M |
| 01/08/2025 | Q2 2025 | -$0.11 | -$0.26 | -0.15 | $70.93 M | $72.85 M |
| 10/03/2024 | Q1 2025 | -$0.15 | -$0.31 | -0.16 | $67.93 M | $67.49 M |
| 07/25/2024 | Q4 2024 | N/A | -$0.33 | N/A | $70.86 M | $70.98 M |
| 04/09/2024 | Q3 2024 | N/A | -$4.67 | N/A | $74.21 M | $75.18 M |
| 01/08/2024 | Q2 2024 | N/A | -$0.72 | N/A | $143.14 M | $79.07 M |
| 10/05/2023 | Q1 2024 | N/A | $1.15 | N/A | $86.29 M | $78.68 M |
| 08/03/2023 | Q4 2023 | N/A | -$0.54 | N/A | N/A | $91.07 M |
| 03/31/2023 | Q3 2023 | N/A | -$0.24 | N/A | $104.87 M | $80.71 M |
| 01/06/2023 | Q2 2023 | N/A | -$0.21 | N/A | $153.09 M | $85.43 M |
| 10/11/2022 | Q1 2023 | N/A | -$0.33 | N/A | $83.43 M | $81.54 M |
| 07/22/2022 | Q4 2022 | N/A | -$0.16 | N/A | $82.92 M | $87.00 M |
| 04/07/2022 | Q3 2022 | $0.01 | -$0.13 | -0.14 | $76.32 M | $73.97 M |
| 01/07/2022 | Q2 2022 | N/A | -$0.21 | N/A | $77.91 M | $78.28 M |
| 09/30/2021 | Q1 2022 | -$0.05 | -$0.18 | -0.13 | $71.30 M | $76.97 M |
| 07/27/2021 | Q4 2021 | N/A | -$0.51 | N/A | $72.67 M | $76.84 M |
| 03/31/2021 | Q3 2021 | N/A | -$0.09 | N/A | $68.95 M | $71.18 M |
| 01/08/2021 | Q2 2021 | N/A | -$0.11 | N/A | $67.35 M | $72.77 M |
AngioDynamics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, January 8th, 2026 based offlast year's report dates.
In the previous quarter, AngioDynamics, Inc. (:ANGO) reported $-0.1 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.14 by $0.04.
The conference call for AngioDynamics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for AngioDynamics, Inc.'s latest earnings report can be read online.
AngioDynamics, Inc. (:ANGO) has a recorded annual revenue of $292.50 M.
AngioDynamics, Inc. (:ANGO) has a recorded net income of $-33,993,000.AngioDynamics, Inc. has generated $-0.83 earnings per share over the last four quarters.
AngioDynamics, Inc. (:ANGO) has a price-to-earnings ratio of -17.28 and price/earnings-to-growth ratio is -2.87.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED